An integral member of the Stratenym team, Jake formulates strategic guidance for our clients, notably spearheading a new algorithm to guide market access teams on selecting and optimizing value messaging for different contexts. In his time with Stratenym, Jake has contributed to a diverse set of projects, from core value dossiers to submissions to HTA agencies in the UK, Canada, and Australia. Therapeutic areas he has worked on include advanced systemic mastocytosis, hereditary transthyretin-related amyloidosis, and primary hyperoxaluria type 1.
With an academic background in microbiology and immunology, Jake is a skilled research writer with over 25 peer-reviewed publications. He has previously led communications with regulatory agencies.
Jake lives in London, Ontario with his wife and young daughter. In his spare time, he enjoys golfing and going for long hikes with his family and two border collies.